[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100537230":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":21,"centralContacts":28,"locations":37,"responsibleParty":102,"collaborators":104,"id":110,"slug":111,"hasResults":112,"nctId":113,"briefTitle":114,"officialTitle":114,"acronym":115,"eligibilityCriteria":116,"healthyVolunteers":112,"sex":117,"minAge":118,"maxAge":119,"enrollmentInfo":120,"targetDuration":12,"studyType":123,"phases":124,"briefSummary":126,"conditions":127,"keywords":12,"overallStatus":40,"whyStopped":12,"lastUpdateSubmitDate":132,"lastUpdatePostDateStruct":133,"startDateStruct":136,"completionDateStruct":138,"leadSponsor":140,"locationsCount":141},{"fullName":5,"class":6},"Weill Medical College of Cornell University","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Usual care","NO_INTERVENTION","Prior to institutional crossover, participants receive care as per usual for 6 months (\"run-in\" period) and are not sent CONSYDER.",null,{"label":14,"type":6,"description":15,"interventionNames":16},"CONSYDER decision aid","Web-based breast cancer surgery decision aid",[17],"Other: CONSYDER decision aid",[19],{"type":6,"name":14,"description":15,"armGroupLabels":20,"otherNames":12},[14],[22,25],{"name":23,"affiliation":5,"role":24},"Shoshana Rosenberg, ScD, MPH","PRINCIPAL_INVESTIGATOR",{"name":26,"affiliation":27,"role":24},"Rachel Greenup, MD, MPH","Yale University",[29,33],{"name":23,"role":30,"phone":31,"phoneExt":12,"email":32},"CONTACT","646-962-8041","shr4009@med.cornell.edu",{"name":34,"role":30,"phone":35,"phoneExt":12,"email":36},"Darima Dorzhieva","646-962-8666","dad4011@med.cornell.edu",[38,57,73,86],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Yale Cancer Center","RECRUITING","New Haven","Connecticut","06510","United States","US",{"type":47,"coordinates":48},"Point",[49,50],-72.92816,41.30815,{"lat":50,"lon":49},[53,56],{"name":26,"role":30,"phone":54,"phoneExt":12,"email":55},"203-737-2966","rachel.greenup@yale.edu",{"name":26,"role":24,"phone":12,"phoneExt":12,"email":12},{"facility":58,"status":40,"city":59,"state":60,"zip":61,"country":44,"countryCode":45,"cosmosGeoPoint":62,"geoPoint":66,"contacts":67},"Dana-Farber Cancer Institute","Boston","Massachusetts","02215",{"type":47,"coordinates":63},[64,65],-71.05977,42.35843,{"lat":65,"lon":64},[68,72],{"name":69,"role":30,"phone":70,"phoneExt":12,"email":71},"Ann Partridge, MD, MPH","617-632-3800","ann_partridge@dfci.harvard.edu",{"name":69,"role":24,"phone":12,"phoneExt":12,"email":12},{"facility":74,"status":40,"city":75,"state":75,"zip":76,"country":44,"countryCode":45,"cosmosGeoPoint":77,"geoPoint":81,"contacts":82},"Weill Cornell Medicine","New York","10065",{"type":47,"coordinates":78},[79,80],-74.00597,40.71427,{"lat":80,"lon":79},[83,84,85],{"name":23,"role":30,"phone":31,"phoneExt":12,"email":32},{"name":34,"role":30,"phone":35,"phoneExt":12,"email":36},{"name":23,"role":24,"phone":12,"phoneExt":12,"email":12},{"facility":87,"status":40,"city":88,"state":89,"zip":90,"country":44,"countryCode":45,"cosmosGeoPoint":91,"geoPoint":95,"contacts":96},"Duke Cancer Institute","Durham","North Carolina","27710",{"type":47,"coordinates":92},[93,94],-78.89862,35.99403,{"lat":94,"lon":93},[97,101],{"name":98,"role":30,"phone":99,"phoneExt":12,"email":100},"Jennifer Plichta, MD, MS","919-681-9156","jennifer.plichta@duke.edu",{"name":98,"role":24,"phone":12,"phoneExt":12,"email":12},{"type":103,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR",[105,108],{"name":106,"class":107},"National Institutes of Health (NIH)","NIH",{"name":109,"class":107},"National Cancer Institute (NCI)","100537230","optimizing-surgical-decisions-in-young-adults-with-breast-cancer-100537230",false,"NCT06275126","Optimizing Surgical Decisions in Young Adults With Breast Cancer","CONSYDER","Inclusion Criteria:\n\n* Female aged 18-44\n* New diagnosis of Stage 0, 1, 2, or 3 unilateral breast cancer\n* English or Spanish speaking\n\nExclusion Criteria:\n\n* Diagnosis of de novo Stage 4 breast cancer\n* Recurrent early-stage breast cancer\n* Bilateral breast cancer","FEMALE","18 Years","44 Years",{"count":121,"type":122},800,"ESTIMATED","INTERVENTIONAL",[125],"NA","The goal of this study is to understand and improve the breast surgical decision-making process for young women newly diagnosed with breast cancer. As part of this study, the investigators will evaluate the impact and use a web-based tool called CONSYDER that is designed to provide useful information to young breast cancer patients. It is also meant to improve communication between young women and their surgeons with the purpose of helping patients make appropriate surgical decisions.\n\nParticipants will complete surveys approximately within 1 week of the surgical consult and approximately 6 months after surgery. Patients who receive neoadjuvant chemotherapy will also be surveyed after the completion of neoadjuvant treatment but prior to surgery. Some patients will be invited for an interview after their surgery as part of the evaluation. A subset of patients\u002Fsurgeons will also have their surgical consultation audio-recorded.",[128,129,130,131],"Breast Cancer Stage 0","Breast Cancer Stage I","Breast Cancer Stage II","Breast Cancer Stage III","2025-09-02",{"date":134,"type":135},"2025-09-09","ACTUAL",{"date":137,"type":135},"2024-03-13",{"date":139,"type":122},"2027-08-31",{"name":5,"class":6},4]